A good rucksack or backpack is essential for any trekking, hiking or wilderness expeditions. Our range of rucksacks have all been carefully selected for their performance, durability and quality. From ...

Arvinas (NASDAQ:ARVN – Free Report) had its price objective decreased by Bank of America from $54.00 to $28.00 in a research report report published on Wednesday morning,Benzinga reports.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Arvinas, Inc. (ARVN) shares soared 8.8% in the last trading session to close at $9.03. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Fintel reports that on March 12, 2025, Wedbush downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Outperform to Neutral. Analyst Price Forecast Suggests 554.89% Upside As of March 4 ...

Pfizer (NYSE:PFE) and its partner Arvinas (NASDAQ:ARVN) for the experimental breast cancer drug vepdegestrant announced mixed initial results from a Phase 3 trial for the protein degrader on Tuesday.

Price Action: ARVN stock is down 52.4% at $8.35 at the last check Tuesday.

Investing.com -- Shares of Arvinas, Inc. (NASDAQ:ARVN) plummeted 41% today following the announcement of positive topline results from its Phase 3 VERITAC-2 clinical trial. Despite meeting its ...

Mixed clinical results led shares of Arvinas Inc. (NASDAQ:ARVN) to close March 11 at $8.30, down $9.26, or 52%, after the company and Pfizer Inc. disclosed results from the phase III Veritac-2 study ...

If that’s not quite your speed, then keep reading. We’ve got a few more top-notch waterproof backpacks to cover your needs. When shopping for waterproof backpacks, it’s important to read ...